Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.
Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.
Enveda Biosciences is a biotechnology company that develops novel medications derived from plants.
OSPRI is updating the infectious illness testing plan.
Amalgam Rx develops and distributes digital health products that support patients and healthcare providers in decision-making.
Superluminal Medicines is a generative biological and chemical company that innovates drug discovery and development processes.
ArriVent develops pharmaceutical products to cure presently untreatable cancer.
Visby Medical is a diagnostics company that develops polymerase chain reaction diagnostic tests for the detection of infectious diseases.
Syndeio Biosciences is a newly launched biotech company pioneering precision neurotherapeutics.
GlycoEra is a biotechnology research company that produces extracellular protein degraders for the treatment of autoimmune diseases.
Xilis is an oncology and precision health company that provides technologies to diagnoses cancer.
Perceive Pharma operates as a pharmaceutical company.
DNA Script is a disruptive DNA synthesis company harnessing biology to accelerate breakthroughs in life science and human health.
PinkDx is a biotechnology company.
Medical Informatics offers solutions that give care teams access to the data they need to take action for alarm management and safety.
ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.
Orasis Pharmaceuticals is an ophthalmic pharmaceutical company that develops eye drops for the treatment of presbyopia.
Noetik is an AI-native biotechnology company that applies machine learning to large-scale human multimodal spatial omics datasets.
EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.
Elektrofi develops hyper concentration microparticle technology for subcutaneous biologic medicine delivery.
Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.
Catalio Capital Management has invested in 137 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Catalio Capital Management's top investment sectors include Biotechnology, Medical, Life Science, Health Care, Therapeutics. The firm invests across 20 different industry categories.
Among tracked funding rounds, Odyssey Therapeutics received $213.0M in a Series D round. Catalio Capital Management's total known invested capital is $10.0B.
Catalio Capital Management's average investment size is $76.1M across its portfolio of 137 companies.
Recent Catalio Capital Management portfolio additions include Star Therapeutics, Cartography Biosciences, Volastra Therapeutics, Ensoma, Odyssey Therapeutics. These companies were founded in 2020 or later.